LL-37
Healing & Recovery
An antimicrobial peptide reported for fighting infections and modulating immune response.
64%
Avg. Benefit Score
1
Reported Benefits
30%
Side Effect Rate
1
Dosing Patterns
People use this for
Benefit Profile
LL-37's fingerprint across categories
Community Interest
Report volume over 12 months
+18% YoY
52
Reports this month
42
Monthly average
500
Total reports
Reported Benefits
1 of 1Infection Fighting
MixedReport frequency64%
1 reports
Community Reports
"Finally seeing progress against my chronic Lyme after adding LL-37 to my protocol."
Reported Side Effects
1Moderate
Die-off symptoms when fighting infections.
Dosing Patterns
1 SubQ
Most Popular: SubQ at 50-100 mcg
70% of community members report using this dosing protocol 1x daily. Individual responses vary — start low and adjust based on your experience.
Commonly Stacked With
Frequently Asked
LL-37 is a human cathelicidin antimicrobial peptide with broad-spectrum antimicrobial activity.
Was this helpful?